Abstract
Introduction: Pregabalin is a gamma-aminobutyric acid (GABA) analogue approved for the treatment of neuropathic pain, partial seizure and generalized anxiety disorder. As a GABA analogue, there is a raising concern regarding the abuse potential of this drug.
Case: We present a first case of pregabalin dependence in a 26-year-old woman without a previous history of illicit drug abuse.
Discussion: Physician should be aware about the addictive potential of pregabalin even in patients without a previous history of substance abuse.
Keywords: Bipolar disorder, pregabalin, substance abuse.
Current Drug Safety
Title:Pregabalin Dependence: A Case Report
Volume: 10 Issue: 2
Author(s): Athar Halaby, Sandra Abou Kassm and Wadih J. Naja
Affiliation:
Keywords: Bipolar disorder, pregabalin, substance abuse.
Abstract: Introduction: Pregabalin is a gamma-aminobutyric acid (GABA) analogue approved for the treatment of neuropathic pain, partial seizure and generalized anxiety disorder. As a GABA analogue, there is a raising concern regarding the abuse potential of this drug.
Case: We present a first case of pregabalin dependence in a 26-year-old woman without a previous history of illicit drug abuse.
Discussion: Physician should be aware about the addictive potential of pregabalin even in patients without a previous history of substance abuse.
Export Options
About this article
Cite this article as:
Halaby Athar, Kassm Abou Sandra and Naja J. Wadih, Pregabalin Dependence: A Case Report, Current Drug Safety 2015; 10 (2) . https://dx.doi.org/10.2174/1574886309666141022101956
DOI https://dx.doi.org/10.2174/1574886309666141022101956 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
P2X7 Receptors: Channels, Pores and More
CNS & Neurological Disorders - Drug Targets Emerging Use of Nanotechnology in the Treatment of Neurological Disorders
Current Pharmaceutical Design Effects of Low Doses of Polyunsaturated Fatty Acids on the Attention Deficit/Hyperactivity Disorder of Children: A Systematic Review
Current Neuropharmacology Structure-Based Design of Benzimidazole Sugar Conjugates: Synthesis, SAR and In Vivo Anti-inflammatory and Analgesic Activities
Medicinal Chemistry Simultaneous Determination of Cytochrome P450 Oxidation Capacity in Humans: A Review on the Phenotyping Cocktail Approach
Current Pharmaceutical Biotechnology Targeting Voltage-Gated Sodium Channels for Treating Neuropathic and Inflammatory Pain
Current Pharmaceutical Biotechnology Role of NUCB2/nesfatin-1 as a Possible Biomarker
Current Pharmaceutical Design Structure-Activity Relationships for Serotonin Transporter and Dopamine Receptor Selectivity
Medicinal Chemistry Seizures and Sodium Hydrogen Exchangers: Potential of Sodium Hydrogen Exchanger Inhibitors as Novel Anticonvulsants
CNS & Neurological Disorders - Drug Targets Genes Underlying Monogenic and Multigenic Epilepsies in Mice
Current Genomics New Route to Synthesize Fluorine Substituted Lamotrigine Drug Analogues as an Anti-Inflammatory Agent
Current Organic Synthesis Dry Age-Related Macular Degeneration: Recent Progress of Therapeutic approaches
Current Molecular Pharmacology Trends and Applications of Brain Computer Interfaces
Current Signal Transduction Therapy Melatonin in the Biliary Tract and Liver: Health Implications
Current Pharmaceutical Design Menthone Aryl Acid Hydrazones: A New Class of Anticonvulsants
Medicinal Chemistry ABC Transporters in the CNS – An Inventory
Current Pharmaceutical Biotechnology Traumatic Brain Injury and Blood-Brain Barrier Cross-Talk
CNS & Neurological Disorders - Drug Targets Involvement of Membrane Channels in Autoimmune Disorders
Current Pharmaceutical Design High-throughput Genotyping Methods for Pharmacogenomic Studies
Current Pharmacogenomics Glycogen Metabolism and Brain Pathologies
Central Nervous System Agents in Medicinal Chemistry